Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP vs Dexamethasone for TMJ Internal Derangement
NCT07691684Completed
- Sponsor
- University of Anbar
- Start
- Dec 2025
- Primary completion
- Apr 2026
- Countries
- 1
01
Overview
Randomised, single-blind trial of platelet-rich plasma and dexamethasone in temporomandibular joint internal derangement (TMJID) (3 arms), sponsored by University of Anbar. Primary endpoint: Pain Intensity at 1 week. Started Dec 2025; status: completed.
02
Drugs
platelet-rich plasmadexamethasone
03
Conditions
temporomandibular joint internal derangement (TMJID)
Beyond the preview
Go deeper on NCT07691684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07691684.